Axsome Therapeutics Overview
Axsome Therapeutics Target Price
Analysts' 12-month price predictions for AXSM.
Get informed when a big investor buys or sells
+ FollowShare Price
$241.97
Average Target Price
$260.50
7.7% upside
7.7% upside22 analysts in the last 4 months
High: $380 | Low: $202
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-11 | JefferiesAndrew Tsai | $380 | 57% upside |  |
| 2026-05-05 | Deutsche BankDavid Hoang | $280 | 15.7% upside | |
| 2026-05-05 | Morgan Stanley | $242 | 0% upside | |
| 2026-05-05 | Needham | $267 | 10.3% upside | |
| 2026-05-05 | RBC CapitalLeonid Timashev | $302 | 24.8% upside | |
| 2026-05-05 | Robert W. BairdBrian Skorney | $246 | 1.7% upside | |
| 2026-05-05 | H.C. Wainwright | $290 | 19.8% upside | |
| 2026-05-04 | Oppenheimer | $280 | 15.7% upside | |
| 2026-05-04 | GuggenheimYatin Suneja | $260 | 7.5% upside | |
| 2026-05-04 | Piper Sandler | $258 | 6.6% upside | |
| 2026-05-04 | Cantor Fitzgerald | $272 | 12.4% upside | |
| 2026-05-04 | JefferiesAndrew Tsai | $275 | 13.7% upside | |
| 2026-05-04 | Deutsche BankDavid Hoang | $281 | 16.1% upside | |
| 2026-05-04 | H.C. WainwrightRaghuram Selvaraju | $270 | 11.6% upside | |
| 2026-05-01 | Oppenheimer | $250 | 3.3% upside | |
| 2026-04-30 | Morgan Stanley | $217 |  10.3% downside | |
| 2026-04-10 | UBS | $259 | 7% upside | |
| 2026-02-24 | RBC Capital | $222 | 8.3% downside | |
| 2026-02-24 | UBS | $251 | 3.7% upside | |
| 2026-02-24 | Morgan Stanley | $207 | 14.5% downside | |
| 2026-02-24 | Guggenheim | $220 | 9.1% downside | |
| 2026-02-24 | Wells Fargo | $202 | 16.5% downside | |
| 2026-02-23 | Wolfe ResearchRudy Li | $230 | 4.9% downside | |
| 2026-02-23 | Truist FinancialJoon Lee | $200 | 17.3% downside | |
| 2026-02-23 | Jefferies | $215 | 11.1% downside | |
| 2026-02-19 | Mizuho Securities | $230 | 4.9% downside | |
| 2026-01-21 | RBC CapitalLeonid Timashev | $219 | 9.5% downside | |
| 2026-01-20 | H.C. Wainwright | $260 | 7.5% upside | |
| 2026-01-16 | Piper Sandler | $223 | 7.8% downside | |
| 2026-01-13 | Robert W. Baird | $209 | 13.6% downside | |
| 2026-01-13 | Wells Fargo | $193 | 20.2% downside | |
| 2026-01-08 | Morgan Stanley | $204 | 15.7% downside | |
| 2026-01-06 | UBS | $248 | 2.5% upside | |
| 2026-01-05 | NeedhamAmi Fadia | $225 | 7% downside | |
| 2026-01-05 | H.C. WainwrightRaghuram Selvaraju | $200 | 17.3% downside | |
| 2026-01-02 | GuggenheimYatin Suneja | $205 | 15.3% downside | |
| 2025-12-31 | Mizuho SecuritiesGraig Suvannavejh | $217 | 10.3% downside | |
| 2025-12-31 | OppenheimerJay Olson | $220 | 9.1% downside | |
| 2025-11-04 | H.C. Wainwright | $185 | 23.5% downside | |
| 2025-11-04 | RBC Capital | $198 | 18.2% downside | |
| 2025-11-04 | Morgan Stanley | $196 | 19% downside | |
| 2025-11-04 | Wells Fargo | $157 | 35.1% downside | |
| 2025-10-20 | Morgan StanleySean Laaman | $194 | 19.8% downside | |
| 2025-09-02 | Wells Fargo | $163 | 32.6% downside | |
| 2025-05-06 | Robert W. BairdJoel Beatty | $162 | 33% downside | |
| 2025-03-27 | Mizuho SecuritiesGraig Suvannavejh | $216 | 10.7% downside | |
| 2025-03-03 | Robert W. Baird | $160 | 33.9% downside | |
| 2025-02-03 | Mizuho SecuritiesGraig Suvannavejh | $137 | 43.4% downside | |
| 2025-02-03 | Truist FinancialJoon Lee | $190 | 21.5% downside | |
| 2025-02-03 | Robert W. BairdJoel Beatty | $132 | 45.4% downside | |